Kyoto, Japan

Daisuke Kawakami

This inventor holds 5 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Shimadzu Corporation, Mcbi, Inc., National Cerebral and Cardiovascular Center. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daisuke Kawakami. Retrieved from https://idiyas.com/inventor/daisuke-kawakami-jr6e5rnx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Daisuke Kawakami: Innovator in Medical Technology

Introduction

Daisuke Kawakami is a distinguished inventor based in Kyoto, Japan, known for his contributions to medical technology. With a total of five patents, Kawakami has made significant strides in the field of disease detection and treatment support systems. His innovative spirit and dedication to research have established him as a notable figure in the medical invention landscape.

Latest Patents

Kawakami's most recent patents showcase his commitment to improving healthcare. One of his latest inventions is a **Cerebral Infarction Treatment Support System**. This system incorporates a detection device, a display, and an image controller. The image controller is designed to receive both first information generated by the detection device and second information related to susceptibility genes based on the first information. It then outputs this information to the display, enhancing the treatment process for cerebral infarctions.

Another notable invention is a **Disease Detection Method**. This method involves detecting a specific disease through measurement results that determine the amount of a peptide, serving as a biomarker in a biological sample using LC-MS (Liquid Chromatography-Mass Spectrometry). The process includes preparing a mixed sample solution, boiling it, and using a solid-phase extraction column to elute the peptide for analysis. This innovative method has the potential to advance diagnostic capabilities in the medical field.

Career Highlights

Daisuke Kawakami has gained valuable experience while working with prestigious organizations. He has contributed to the development of medical technologies at Shimadzu Corporation, a company renowned for its advanced analytical and measuring instruments. Additionally, he has been involved with Mcbi, Inc., where he collaborated on various innovative projects.

Collaborations

Throughout his career, Kawakami has worked alongside esteemed colleagues, including Hiroshi Muraoka and Nobuhiro Hanafusa. These collaborations have fostered an environment of creativity and innovative thinking, which is evident in Kawakami's impressive patent portfolio.

Conclusion

Daisuke Kawakami's innovations in medical technology demonstrate his commitment to enhancing healthcare through advanced solutions. His latest patents reflect a forward-thinking approach that could redefine disease detection and treatment methodologies. With his ongoing contributions, Kawakami continues to inspire future generations of inventors in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…